125 related articles for article (PubMed ID: 25795716)
1. Post-transplant molecularly defined Burkitt lymphomas are frequently MYC-negative and characterized by the 11q-gain/loss pattern.
Ferreiro JF; Morscio J; Dierickx D; Marcelis L; Verhoef G; Vandenberghe P; Tousseyn T; Wlodarska I
Haematologica; 2015 Jul; 100(7):e275-9. PubMed ID: 25795716
[No Abstract] [Full Text] [Related]
2. Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients.
Zimmermann H; Reinke P; Neuhaus R; Lehmkuhl H; Oertel S; Atta J; Planker M; Gärtner B; Lenze D; Anagnostopoulos I; Riess H; Trappe RU
Cancer; 2012 Oct; 118(19):4715-24. PubMed ID: 22392525
[TBL] [Abstract][Full Text] [Related]
3. Genetic progression of post-transplant Burkitt-like lymphoma case with 11q-Gain/Loss and MYC amplification.
Grygalewicz B; Woroniecka R; Rymkiewicz G; Rygier J; Malawska N; Blachnio K; Bystydzienski Z; Borysiuk A; Nowakowska B; Pienkowska-Grela B
Cancer Genet; 2020 Jul; 245():1-5. PubMed ID: 32531723
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
Green TM; Young KH; Visco C; Xu-Monette ZY; Orazi A; Go RS; Nielsen O; Gadeberg OV; Mourits-Andersen T; Frederiksen M; Pedersen LM; Møller MB
J Clin Oncol; 2012 Oct; 30(28):3460-7. PubMed ID: 22665537
[TBL] [Abstract][Full Text] [Related]
5. Post cardiac transplantation lymphoproliferative disorder presenting as t(8;14) Burkitt leukaemia/lymphoma treated with low intensity chemotherapy and rituximab.
Windebank K; Walwyn T; Kirk R; Parry G; Hasan A; Bown N; Wilkins B
Pediatr Blood Cancer; 2009 Sep; 53(3):392-6. PubMed ID: 19459198
[TBL] [Abstract][Full Text] [Related]
6. Indications and results of chemotherapy in children with posttransplant lymphoproliferative disease after liver transplantation.
Smets F; Vajro P; Cornu G; Reding R; Otte JB; Sokal E
Transplantation; 2000 Mar; 69(5):982-4. PubMed ID: 10755561
[TBL] [Abstract][Full Text] [Related]
7. A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma.
Salaverria I; Martin-Guerrero I; Wagener R; Kreuz M; Kohler CW; Richter J; Pienkowska-Grela B; Adam P; Burkhardt B; Claviez A; Damm-Welk C; Drexler HG; Hummel M; Jaffe ES; Küppers R; Lefebvre C; Lisfeld J; Löffler M; Macleod RA; Nagel I; Oschlies I; Rosolowski M; Russell RB; Rymkiewicz G; Schindler D; Schlesner M; Scholtysik R; Schwaenen C; Spang R; Szczepanowski M; Trümper L; Vater I; Wessendorf S; Klapper W; Siebert R; ;
Blood; 2014 Feb; 123(8):1187-98. PubMed ID: 24398325
[TBL] [Abstract][Full Text] [Related]
8. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
Muti G; Cantoni S; Oreste P; Klersy C; Gini G; Rossi V; D'Avanzo G; Comoli P; Baldanti F; Montillo M; Nosari A; Morra E;
Haematologica; 2002 Jan; 87(1):67-77. PubMed ID: 11801467
[TBL] [Abstract][Full Text] [Related]
9. Burkitt lymphoma after transplant: an aggressive lymphoproliferative disease.
Akar Özkan E; Özdemir BH; Akdur A; Deniz EE; Haberal M
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():136-8. PubMed ID: 24635811
[TBL] [Abstract][Full Text] [Related]
10. [Gingival Burkitt lymphoma in a hepatitis C-positive renal transplant patient].
Unholzer A; Starz H; Hirschsteiner O; Balda BR
J Dtsch Dermatol Ges; 2005 Jan; 3(1):46-51. PubMed ID: 16353750
[TBL] [Abstract][Full Text] [Related]
11. Rituximab therapy and reduction of immunosuppression to rescue graft function after renal posttransplantation lymphoproliferative disorder found by macrohematuria in a pancreas and kidney transplant recipient: a case report.
Miyagi S; Sekiguchi S; Kawagishi N; Akamatsu Y; Satoh K; Takeda I; Fukushima D; Kobayashi Y; Tokodai K; Fujimori K; Satomi S
Transplant Proc; 2011 Nov; 43(9):3299-301. PubMed ID: 22099782
[TBL] [Abstract][Full Text] [Related]
12. Adult Burkitt lymphoma: advances in diagnosis and treatment.
Aldoss IT; Weisenburger DD; Fu K; Chan WC; Vose JM; Bierman PJ; Bociek RG; Armitage JO
Oncology (Williston Park); 2008 Nov; 22(13):1508-17. PubMed ID: 19133605
[TBL] [Abstract][Full Text] [Related]
13. The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma.
Wagener R; Seufert J; Raimondi F; Bens S; Kleinheinz K; Nagel I; Altmüller J; Thiele H; Hübschmann D; Kohler CW; Nürnberg P; Au-Yeung R; Burkhardt B; Horn H; Leoncini L; Jaffe ES; Ott G; Rymkiewicz G; Schlesner M; Russell RB; Klapper W; Siebert R
Blood; 2019 Feb; 133(9):962-966. PubMed ID: 30567752
[TBL] [Abstract][Full Text] [Related]
14. Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.
Trappe R; Oertel S; Leblond V; Mollee P; Sender M; Reinke P; Neuhaus R; Lehmkuhl H; Horst HA; Salles G; Morschhauser F; Jaccard A; Lamy T; Leithäuser M; Zimmermann H; Anagnostopoulos I; Raphael M; Riess H; Choquet S; ;
Lancet Oncol; 2012 Feb; 13(2):196-206. PubMed ID: 22173060
[TBL] [Abstract][Full Text] [Related]
15. The 11q-Gain/Loss Aberration Occurs Recurrently in MYC-Negative Burkitt-like Lymphoma With 11q Aberration, as Well as MYC-Positive Burkitt Lymphoma and MYC-Positive High-Grade B-Cell Lymphoma, NOS.
Grygalewicz B; Woroniecka R; Rymkiewicz G; Rygier J; Borkowska K; Kotyl A; Blachnio K; Bystydzienski Z; Nowakowska B; Pienkowska-Grela B
Am J Clin Pathol; 2017 Dec; 149(1):17-28. PubMed ID: 29272887
[TBL] [Abstract][Full Text] [Related]
16. Burkitt's lymphoma-- what is new?
Abinya ON
East Afr Med J; 2008 May; 85(5):205-6. PubMed ID: 18814529
[No Abstract] [Full Text] [Related]
17. Burkitt's lymphoma.
Molyneux EM; Rochford R; Griffin B; Newton R; Jackson G; Menon G; Harrison CJ; Israels T; Bailey S
Lancet; 2012 Mar; 379(9822):1234-44. PubMed ID: 22333947
[TBL] [Abstract][Full Text] [Related]
18. Post-transplant Burkitt lymphoma is a more aggressive and distinct form of post-transplant lymphoproliferative disorder.
Picarsic J; Jaffe R; Mazariegos G; Webber SA; Ellis D; Green MD; Reyes-Múgica M
Cancer; 2011 Oct; 117(19):4540-50. PubMed ID: 21446044
[TBL] [Abstract][Full Text] [Related]
19. Late-onset Epstein-Barr virus (EBV)-negative extranodal B-precursor lymphoblastic lymphoma of donor origin after hematopoietic stem cell transplantation (HSCT).
Bredt M; Schönfeld G; Kleeberger W; König E; Kröning H; Kettner E; Al-Ali HK; Niederwieser D; Kreipe H
Bone Marrow Transplant; 2003 Jun; 31(11):1071-2. PubMed ID: 12774065
[No Abstract] [Full Text] [Related]
20. Monotherapy rapamycin in renal transplant recipients with lymphoma successfully treated with rituximab.
Alexandru S; Gonzalez E; Grande C; Hernandez A; Morales E; Praga M; Andres A; Morales JM
Transplant Proc; 2009; 41(6):2435-7. PubMed ID: 19715944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
